Related Experiment Videos
Probiotics as biotherapeutic agents: present knowledge and future prospects
1Laboratory of Bacteriology of Ecosystems, INSERM IFR17, Institut Pasteur de Lille, France. annick.mercenier@rdls.nestle.com
Current Pharmaceutical Design
|February 7, 2003
Summary
Probiotics, primarily lactic acid bacteria, show promise for treating diseases and modulating immunity. Further research is needed to clarify mechanisms and establish regulations for their use as food or medicine.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Lactic acid bacteria have been investigated for health benefits since Metchnikoff's work.
- Probiotic mechanisms in the complex gut ecosystem are not fully understood.
- Clinical trials increasingly support the efficacy of specific probiotic strains for intestinal disorders.
Purpose of the Study:
- To explore the potential of lactic acid bacteria as biotherapeutic agents.
- To address the knowledge gap regarding probiotic mechanisms of action.
- To inform regulatory frameworks for probiotic products.
Main Methods:
- Review of existing experimental and clinical data on lactic acid bacteria.
- Analysis of the gastro-intestinal ecosystem's complexity.
- Consideration of consumer demand for natural health solutions.
Main Results:
- Specific lactic acid bacterial strains demonstrate beneficial effects in clinical trials.
- Evidence supports an immunomodulatory role for certain bacterial strains.
- The probiotic market is poised for growth, driven by consumer interest.
Conclusions:
- Further multidisciplinary research is essential to elucidate probiotic mechanisms.
- Clear regulations based on scientific evidence are needed for market growth.
- Research findings will guide the classification of probiotics as food, supplements, or pharmaceuticals.